Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older - Trial NCT02392754
Access comprehensive clinical trial information for NCT02392754 through Pure Global AI's free database. This phase not specified trial is sponsored by Population Health Research Institute and is currently Completed. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 856 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Screening: Intervention - Atrial fibrillation screening (ZIO XT ECG monitor, Watch-BP)
Interventional
device
Sponsor & Location
Population Health Research Institute
Timeline & Enrollment
N/A
Apr 01, 2015
Jan 21, 2020
Primary Outcome
Detection of new atrial fibrillation or flutter
Summary
Atrial fibrillation (AF) is a major treatable risk factor for stroke, but it may be hard to
 detect because it is frequently silent and intermittent. New ambulatory cardiac monitoring
 technologies have the potential to improve early detection of AF. This trial investigates AF
 screening in primary care patients using the ZIO XT Patch, a wearable adhesive patch monitor
 that provides continuous ECG recording for up to 14 days, in addition to the WatchBP home
 blood pressure monitor that has built-in AF screening capability.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02392754
Device Trial